We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer

This study has been terminated.
(Further evaluation of phase I dosing)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00585416
First Posted: January 3, 2008
Last Update Posted: October 2, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Progen Pharmaceuticals
Information provided by (Responsible Party):
University of Wisconsin, Madison
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2009
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)